News & Updates
Filter by Specialty:
Nonoperative management safe, feasible after complete response in rectal cancer
Patients with locally advanced rectal cancer who achieve complete response (CR) following sequential short-course radiation therapy (SCRT) and chemotherapy appear to benefit from nonoperative management (NOM) with a watch-and-wait strategy, which presents evidence for good anorectal functions, results of a study have shown.
Nonoperative management safe, feasible after complete response in rectal cancer
15 Jul 2022Olaparib safe, effective in ovarian cancer patients with BRCA mutation, HRD
Olaparib demonstrates clinical activity across patients with platinum-sensitive relapsed ovarian cancer and known BRCA mutation and homologous recombination deficiency (HRD), as shown in the phase II LIGHT study.
Olaparib safe, effective in ovarian cancer patients with BRCA mutation, HRD
15 Jul 2022Trastuzumab deruxtecan for HER2-low breast cancer: A treatment for a new population
Trastuzumab deruxtecan led to greater survival outcomes than chemotherapy treatment of physician’s choice (TPC)* in patients with HER2-low** advanced breast cancer, according to results of a phase III trial presented at ASCO 2022.
Trastuzumab deruxtecan for HER2-low breast cancer: A treatment for a new population
14 Jul 2022Thermoelectric warming therapy beneficial in MGD-related dry eye disease
A device that applies consistent emissive heat to the meibomian glandular apparatus appears to produce significant improvements in the signs and symptoms of dry eye disease in patients with meibomian gland dysfunction (MGD), with the benefits sustained over 6 months following treatment initiation, as shown in a study.